Pay in 4 interest-free payments of $5.54 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The peptide is also a clinically proven and FDA-approved treatment
A 12-week randomized trial demonstrated: Average weight loss of 2.6 kg in AOD-9604 group (1 mg/day) versus 0.8 kg in placebo group Preferential reduction in abdominal and visceral fat deposits No adverse effects on carbohydrate metabolism or insulin sensitivity Non-dose-dependent effects, with higher doses (10 mg/day) producing less weight loss than lower doses However, a subsequent 24-week Phase III trial with 502 subjects incorporating intensive diet and exercise showed no statistically significant weight loss compared to placebo, leading to development termination in 2007
A five-minute eligibility check prevents a denial that can take 45 or more days to resolve through the appeal process
Many of the reported improvements associated with NAD+ Injections with NMN and 5-Amino-1MQ involve enhanced mitochondrial function, improved endurance, and better metabolic regulation
Coelho, D., J.C
US$ 22.93
US$ 25.22
US$ 21.78
US$ 23.18
